CG Oncology Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About CG Oncology Inc
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
/ 
Frequently asked questions
To buy CG Oncology Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for CG Oncology Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for CG Oncology Inc is CGON:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
CG Oncology Inc has its primary listing on NASDAQ. You can trade CG Oncology Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, CG Oncology Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include CG Oncology Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like CG Oncology Inc.